DNA guanine N-7 residue (N7-G)

DNA guanine N-7 residues represent a major molecular target for classical chemotherapy. The N7 atom of guanine is highly susceptible to nucleophilic attack by electrophilic drugs, such as nitrogen mustards and platinum-based compounds (NIH: PubChem). When these drugs bind to the N7 position, they create bulky adducts or cross-links between DNA strands, effectively stalling replication forks and transcription complexes (PubMed: PMC113590). This disruption of DNA integrity is particularly lethal to cancer cells, which often have defective DNA repair mechanisms or high rates of division. However, the non-specific nature of this targeting leads to damage in healthy tissues, resulting in side effects like bone marrow suppression and nephrotoxicity (StatPearls: Cisplatin, 2023). Monitoring biomarkers like MGMT or ERCC1 can help predict patient response to these DNA-damaging agents (PubMed: PMC2697323). The accumulation of these lesions eventually triggers the apoptotic cascade in susceptible cells, while common clinical consequences include myelosuppression and the risk of secondary malignancies (StatPearls: Alkylating Agents, 2023).

Other names

N7-guanineGuanine N7 positionN7-deoxyguanosineN7-G DNA adduct siteN7-alkylguanine

Drugs targeting DNA guanine N-7 residues act by forming covalent adducts through alkylation or platination (StatPearls: Alkylating Agents, 2023). This chemical modification creates physical barriers on the DNA template, leading to the formation of interstrand and intrastrand cross-links that block DNA replication and transcription (PubMed: PMC4707177). The accumulation of these lesions eventually triggers the apoptotic cascade in susceptible cells.